Leading Mass Tort Litigation Expert Joseph Fantini Answers Common Zantac Compensation Questions – Philadelphia, PA

Top mass tort injury lawyer Joseph Fantini reveals that people are still unaware of the damage done by banned cancer-causing drug Zantac and the legal channels open to them to pursue compensation. For more information please visit https://www.zantacsupport.org

Jenkintown, PA, United States – May 10, 2021 /MM-REB/ —

Too many people across the U.S. are still unaware of the damage done by banned cancer-causing drug Zantac and the legal channels open to them to pursue compensation, a legal expert has revealed.

For more information please visit https://www.zantacsupport.org/

Joseph Fantini, founder of the Zantac Cancer Compensation Program (ZCCP) and managing attorney at Philadelphia-based Rosen Injury Lawyers, recently spoke out about the problem and made the comments during an episode of 5 Minute Legal Insights podcast.

ZCCP estimate there are over 75,000 individuals in legal claims, and Fantini fully expects the final figure to more than double.

When asked to comment Fantini said, “The U.S. Food and Drug Administration (FDA) took the unusual step in April 2020 in recalling ranitidine, the generic version of Zantac, over concerns of a potentially high dosage content of N-Nitrosodimethylamine (NDMA), a known carcinogen, in the drug.”

Tests revealed Zantac could have 3,000 times more NDMA content than the FDA’s recommended daily dose. NDMA can cause several cancers affecting the prostate, bladder, breast, colon, oesophagal, gastric, kidney, liver, pancreatic, and stomach.

Fantini addressed several frequently asked questions about Zantac, Zantac Cancer Compensation Program’s role, and likely outcomes during the podcast.

He said: “We are presently reviewing ten different types of cancers after our clients took Zantac. Whether they took Zantac eight years ago or one year ago, studies show correlations between the end date of taking Zantac and a person later developing cancer.

“If someone took Zantac for more than a year and was later diagnosed with one of those cancers, we would be interested in talking to them.”

ZCCP brings together the best of the legal and medical world under one roof in helping build legal cases concerning Zantac. “For a client, we get two medical records, one from their primary care physician demonstrating proof of use of Zantac, and the other an oncologist or physician who was treating them,” he explained.

Their experts evaluate the reports before deciding on how to move forward. “We treat each individual on a case by case basis. Each one is different and involves many factors such as how long they took Zantac, their age, their diagnosed cancer and the treatment they had.“

He added: “Once we reach a decision, we will reach out to a client and discuss the next step. We will be honest with them, and if we can’t take on their case, we will explain our reasons. We are not going to string them along or create a false narrative. We want to help as many people as possible, and it’s our ethical obligation to tell the truth.”

Fantini said a typical legal medical case can take between three to five years before concluding. “Experience in this type of case shows 98% of claims are usually settled before they go to trial. However, we appreciate there will always be one case that may go to court and ZCCP is ready to stand up and fight. We have the resources to get the compensation a client deserves.”

Source: http://RecommendedExperts.biz

Contact Info:
Name: Joseph Fantini
Email: Send Email
Organization: Rosen Injury Lawyers – Zantac
Address: 101 Greenwood Ave, Jenkintown, PA 19046, United States
Phone: (215) 310-9961
Website: https://www.zantacsupport.org

Source: MM-REB

Release ID: 89011032